<!DOCTYPE html>
<html lang="zh-CN">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="chapt 11.6 æ²¹èœç´ ç”¾é†‡  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ²¹èœç´ ç”¾é†‡ (Brassinosteroids, BRs): ä¸€ç±»å¤šç¾ŸåŸºç”¾é†‡ç±»æ¤ç‰©æ¿€ç´ ï¼Œç»“æ„ä¸Šä¸åŠ¨ç‰©ç±»å›ºé†‡æ¿€ç´ ï¼ˆå¦‚é›„æ€§æ¿€ç´ ã€èœ•çš®æ¿€ç´ ï¼‰ç›¸ä¼¼ã€‚å®ƒæ˜¯æ¤ç‰©ä½“å†…ç¬¬å…­å¤§ç±»æ¿€ç´ ï¼Œä¸»è¦åŠŸèƒ½åŒ…æ‹¬ä¿ƒè¿›ç»†èƒä¼¸é•¿å’Œåˆ†è£‚ã€ç»´ç®¡æŸåˆ†åŒ–ã€ç”Ÿæ®–å‘è‚²ä»¥åŠæŠ—é€†ç­‰ã€‚ ---  äºŒ...">
    <meta name="keywords" content="æ¤ç‰©ç”Ÿç†å­¦/ååŠ, chapt 11.6 æ²¹èœç´ ç”¾é†‡">
    <meta name="author" content="Yukari502">
    <meta name="article-slug" content="chapt-116-æ²¹èœç´ ç”¾é†‡">
    <meta name="root-path" content="../../">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-116-æ²¹èœç´ ç”¾é†‡.html">
    <meta property="og:title" content="chapt 11.6 æ²¹èœç´ ç”¾é†‡">
    <meta property="og:description" content="chapt 11.6 æ²¹èœç´ ç”¾é†‡  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ²¹èœç´ ç”¾é†‡ (Brassinosteroids, BRs): ä¸€ç±»å¤šç¾ŸåŸºç”¾é†‡ç±»æ¤ç‰©æ¿€ç´ ï¼Œç»“æ„ä¸Šä¸åŠ¨ç‰©ç±»å›ºé†‡æ¿€ç´ ï¼ˆå¦‚é›„æ€§æ¿€ç´ ã€èœ•çš®æ¿€ç´ ï¼‰ç›¸ä¼¼ã€‚å®ƒæ˜¯æ¤ç‰©ä½“å†…ç¬¬å…­å¤§ç±»æ¿€ç´ ï¼Œä¸»è¦åŠŸèƒ½åŒ…æ‹¬ä¿ƒè¿›ç»†èƒä¼¸é•¿å’Œåˆ†è£‚ã€ç»´ç®¡æŸåˆ†åŒ–ã€ç”Ÿæ®–å‘è‚²ä»¥åŠæŠ—é€†ç­‰ã€‚ ---  äºŒ...">
    <meta property="og:site_name" content="Digital Garden">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://yukari502.github.io/posts/æ¤ç‰©ç”Ÿç†å­¦ååŠ/chapt-116-æ²¹èœç´ ç”¾é†‡.html">
    <meta property="twitter:title" content="chapt 11.6 æ²¹èœç´ ç”¾é†‡">
    <meta property="twitter:description" content="chapt 11.6 æ²¹èœç´ ç”¾é†‡  ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š æ²¹èœç´ ç”¾é†‡ (Brassinosteroids, BRs): ä¸€ç±»å¤šç¾ŸåŸºç”¾é†‡ç±»æ¤ç‰©æ¿€ç´ ï¼Œç»“æ„ä¸Šä¸åŠ¨ç‰©ç±»å›ºé†‡æ¿€ç´ ï¼ˆå¦‚é›„æ€§æ¿€ç´ ã€èœ•çš®æ¿€ç´ ï¼‰ç›¸ä¼¼ã€‚å®ƒæ˜¯æ¤ç‰©ä½“å†…ç¬¬å…­å¤§ç±»æ¿€ç´ ï¼Œä¸»è¦åŠŸèƒ½åŒ…æ‹¬ä¿ƒè¿›ç»†èƒä¼¸é•¿å’Œåˆ†è£‚ã€ç»´ç®¡æŸåˆ†åŒ–ã€ç”Ÿæ®–å‘è‚²ä»¥åŠæŠ—é€†ç­‰ã€‚ ---  äºŒ...">

    <title>chapt 11.6 æ²¹èœç´ ç”¾é†‡ - D.RAY</title>

    <!-- Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Outfit:wght@300;400;500;600;700&family=JetBrains+Mono:wght@400;500&display=swap"
        rel="stylesheet">

    <!-- Highlight.js -->
    <link rel="stylesheet"
        href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/styles/atom-one-dark.min.css">
    <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/11.9.0/highlight.min.js"></script>

    <!-- KaTeX -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js"></script>

    <!-- Marked.js for Markdown parsing -->
    <script src="https://cdn.jsdelivr.net/npm/marked/marked.min.js"></script>

    <!-- Mermaid.js for diagrams and flowcharts -->
    <script type="module">
        import mermaid from 'https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.esm.min.mjs';
        mermaid.initialize({
            startOnLoad: false,
            theme: 'dark',
            themeVariables: {
                primaryColor: '#8b5cf6',
                primaryTextColor: '#fff',
                primaryBorderColor: '#7c3aed',
                lineColor: '#a78bfa',
                secondaryColor: '#6d28d9',
                tertiaryColor: '#5b21b6'
            }
        });
        window.mermaid = mermaid;
    </script>

    <!-- Custom Styles -->
    <link rel="stylesheet" href="../../style.css">
    <link rel="icon" href="../../ico/favicon.ico" type="image/x-icon">

    <style>
        .article-page {
            max-width: 1150px;
            margin: 0 auto;
            padding: 2rem;
        }

        .article-header {
            margin-bottom: 3rem;
            padding-bottom: 2rem;
            border-bottom: 2px solid var(--border-color);
        }

        .article-title {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 1rem;
            line-height: 1.2;
        }

        .article-meta {
            display: flex;
            gap: 1rem;
            color: var(--text-secondary);
            font-size: 0.95rem;
        }

        .article-meta span {
            display: flex;
            align-items: center;
            gap: 0.3rem;
        }

        .back-link {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--accent-color);
            text-decoration: none;
            margin-bottom: 2rem;
            font-weight: 500;
            transition: transform 0.2s;
        }

        .back-link:hover {
            transform: translateX(-4px);
        }

        .article-content {
            font-size: 1.1rem;
            line-height: 1.8;
        }

        @media (max-width: 768px) {
            .article-page {
                padding: 1rem;
            }

            .article-title {
                font-size: 2rem;
            }
        }

        .article-footer {
            margin-top: 4rem;
            padding-top: 2rem;
            border-top: 1px solid var(--border-color);
            text-align: center;
            color: var(--text-secondary);
            font-size: 0.85rem;
        }

        .article-footer .disclaimer {
            font-size: 0.75rem;
            margin-top: 0.5rem;
            font-style: italic;
            opacity: 0.8;
        }
    </style>
    <meta name="build-hash" content="d8e7543bdd11441e5ed16884796ae6c1">
</head>

<body>
    <div class="article-page">
        <a href="../../" class="back-link">
            <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none"
                stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <line x1="19" y1="12" x2="5" y2="12"></line>
                <polyline points="12 19 5 12 12 5"></polyline>
            </svg>
            è¿”å›ä¸»é¡µ
        </a>

        <div class="article-header">
            <h1 class="article-title">chapt 11.6 æ²¹èœç´ ç”¾é†‡</h1>
            <div class="article-meta">
                <span>ğŸ“… 2026-01-14</span>
                <span>ğŸ“‚ æ¤ç‰©ç”Ÿç†å­¦/ååŠ</span>
            </div>
        </div>

        <article class="article-content markdown-body" id="article-content">
            <!-- Content will be rendered here -->
        </article>

        <!-- Store markdown content in a script tag -->
        <script type="text/markdown" id="markdown-source">
# chapt 11.6 æ²¹èœç´ ç”¾é†‡

### ä¸€ã€ é‡ç‚¹åè¯è§£é‡Š

**æ²¹èœç´ ç”¾é†‡ (Brassinosteroids, BRs):** ä¸€ç±»å¤šç¾ŸåŸºç”¾é†‡ç±»æ¤ç‰©æ¿€ç´ ï¼Œç»“æ„ä¸Šä¸åŠ¨ç‰©ç±»å›ºé†‡æ¿€ç´ ï¼ˆå¦‚é›„æ€§æ¿€ç´ ã€èœ•çš®æ¿€ç´ ï¼‰ç›¸ä¼¼ã€‚å®ƒæ˜¯æ¤ç‰©ä½“å†…ç¬¬å…­å¤§ç±»æ¿€ç´ ï¼Œä¸»è¦åŠŸèƒ½åŒ…æ‹¬ä¿ƒè¿›ç»†èƒä¼¸é•¿å’Œåˆ†è£‚ã€ç»´ç®¡æŸåˆ†åŒ–ã€ç”Ÿæ®–å‘è‚²ä»¥åŠæŠ—é€†ç­‰ã€‚

---

### äºŒã€ æ¤ç‰©ç”Ÿç†å­¦é‡ç‚¹å†…å®¹å½’çº³

**3. ç”Ÿç†åŠŸèƒ½**
*   **ç»†èƒæ°´å¹³ï¼š** ä¿ƒè¿›ç»†èƒä¼¸é•¿ï¼ˆCell elongationï¼‰å’Œç»†èƒåˆ†è£‚ï¼ˆCell divisionï¼Œæ¶‰åŠCycD3è¯±å¯¼ï¼‰ã€‚
*   **æ•´ä½“å‘è‚²ï¼š**
    *   **æ ªå‹æ§åˆ¶ï¼š** BRåˆæˆç¼ºé™·å¯¼è‡´æ¤æ ªçŸ®å°ã€å¶ç‰‡æ·±ç»¿ã€å¶å¤¹è§’å˜å°ï¼ˆç›´ç«‹å¶ï¼‰ã€‚é€‚å½“é™ä½BRæ°´å¹³ï¼ˆå¦‚æ°´ç¨» *osdwarf4*ï¼‰å¯ä½¿å¶ç‰‡ç›´ç«‹ï¼Œå¢åŠ å¯†æ¤æ¡ä»¶ä¸‹çš„å…‰åˆæ•ˆç‡ï¼Œä»è€Œæé«˜ä½œç‰©äº§é‡ã€‚
    *   **ç»´ç®¡æŸå‘è‚²ï¼š** ä¿ƒè¿›æœ¨è´¨éƒ¨ï¼ˆXylemï¼‰åˆ†åŒ–ï¼ŒæŠ‘åˆ¶éŸ§çš®éƒ¨ï¼ˆPhloemï¼‰è¿‡åº¦å¢æ®–ã€‚
    *   **å…¶ä»–ï¼š** ä¿ƒè¿›ç§å­èŒå‘ã€ç”Ÿæ®–å‘è‚²ï¼ˆè‚²æ€§ï¼‰ã€å¶ç‰‡è¡°è€åŠæŠ—é€†ååº”ã€‚

**4. ä¿¡å·è½¬å¯¼ (Signal Transduction)**
BRä¿¡å·è½¬å¯¼æ˜¯ä¸€ä¸ª**å»æŠ‘åˆ¶ (Derepression)** è¿‡ç¨‹ï¼š
*   **å—ä½“å¤åˆç‰©ï¼š** ç»†èƒè†œä¸Šçš„ **BRI1** (å—ä½“) å’Œ **BAK1** (å…±å—ä½“)ã€‚
*   **æ— BRæ—¶ï¼ˆå…³é—­çŠ¶æ€ï¼‰ï¼š** BRI1çš„æ¿€é…¶åŸŸè¢« **BKI1** ç»“åˆè€Œå¤±æ´»ã€‚èƒè´¨ä¸­çš„ **BIN2** æ¿€é…¶å¤„äºæ´»æ€§çŠ¶æ€ï¼Œç£·é…¸åŒ–è½¬å½•å› å­ **BZR1/BES1**ã€‚ç£·é…¸åŒ–çš„BZR1/BES1ä¸ **14-3-3è›‹ç™½** ç»“åˆè¢«æ»ç•™åœ¨èƒè´¨ä¸­ï¼Œæˆ–è¢«è›‹ç™½é…¶ä½“é™è§£ï¼Œå¯¼è‡´ä¸‹æ¸¸åŸºå› æ— æ³•è¡¨è¾¾ã€‚
*   **æœ‰BRæ—¶ï¼ˆå¼€å¯çŠ¶æ€ï¼‰ï¼š**
    1.  BRåˆ†å­ç»“åˆBRI1èƒå¤–åŸŸï¼Œå¯¼è‡´BKI1è§£ç¦»ã€‚
    2.  BRI1æ‹›å‹ŸBAK1å¹¶å‘ç”Ÿç›¸äº’ç£·é…¸åŒ–æ¿€æ´»ã€‚
    3.  æ¿€æ´»çš„BRI1ç£·é…¸åŒ– **BSKs/CDG1**ã€‚
    4.  BSKs/CDG1 æ¿€æ´»ç£·é…¸é…¶ **BSU1**ã€‚
    5.  BSU1 ä½¿ **BIN2** å»ç£·é…¸åŒ–å¹¶å¤±æ´»ã€‚
    6.  **PP2A** ç£·é…¸é…¶ä½¿ **BZR1/BES1** å»ç£·é…¸åŒ–ã€‚
    7.  å»ç£·é…¸åŒ–çš„BZR1/BES1 è¿›å…¥ç»†èƒæ ¸ï¼Œè°ƒèŠ‚é¶åŸºå› è¡¨è¾¾ã€‚

---

### ä¸‰ã€ é‡ç‚¹å®éªŒæ¦‚è¿°



**2. æ‹Ÿå—èŠ¥æš—å½¢æ€å»ºæˆçªå˜ä½“ç­›é€‰**
*   **èƒŒæ™¯ï¼š** 1996å¹´ Li, Szekeres ç­‰äººã€‚
*   **å†…å®¹ï¼š** ç­›é€‰åœ¨æš—ä¸­ä¸èƒ½åƒæ­£å¸¸æ¤æ ªé‚£æ ·ä¼¸é•¿ï¼ˆå»é»„åŒ–ï¼‰çš„çªå˜ä½“ã€‚
*   **ç»“æœï¼š** é‰´å®šå‡º *det2* (de-etiolated 2) å’Œ *cpd* (constitutive photomorphogenic dwarf)ã€‚
*   **éªŒè¯ï¼š** å¤–æºæ–½åŠ BRå¯ä»¥æ¢å¤è¿™äº›çªå˜ä½“çš„é‡ç”Ÿå‹è¡¨å‹ã€‚
*   **ç»“è®ºï¼š** è¯æ˜äº†è¿™äº›åŸºå› å‚ä¸BRçš„ç”Ÿç‰©åˆæˆï¼Œä¸”BRå¯¹ç»†èƒä¼¸é•¿è‡³å…³é‡è¦ã€‚


**4. æ ¹ä¼¸é•¿æŠ‘åˆ¶å®éªŒ**
*   **å†…å®¹ï¼š** æ¯”è¾ƒé‡ç”Ÿå‹ (Columbia) å’Œ *bri1* çªå˜ä½“åœ¨ä¸åŒæµ“åº¦ 24-è¡¨æ²¹èœç´ å†…é…¯ (24-epibrassinolide) å¤„ç†ä¸‹çš„æ ¹é•¿ã€‚
*   **ç»“æœï¼š** é‡ç”Ÿå‹æ ¹é•¿éšBRæµ“åº¦å¢åŠ å—åˆ°å¼ºçƒˆæŠ‘åˆ¶ï¼›è€Œ *bri1* çªå˜ä½“çš„æ ¹é•¿å‡ ä¹ä¸å—é«˜æµ“åº¦BRçš„å½±å“ã€‚
*   **ç»“è®ºï¼š** è¿›ä¸€æ­¥è¯å® *bri1* æ˜¯BRä¸æ•æ„Ÿçªå˜ä½“ã€‚

---

### å››ã€ é—®é¢˜å›ç­” (Q&A)

**Q1: How do Brassinosteroids (BRs) differ from animal steroid hormones in terms of perception? (æ²¹èœç´ ç”¾é†‡ä¸åŠ¨ç‰©ç±»å›ºé†‡æ¿€ç´ åœ¨æ„ŸçŸ¥ä¸Šæœ‰ä½•ä¸åŒï¼Ÿ)**
**A:** å°½ç®¡ç»“æ„ç›¸ä¼¼ï¼ŒåŠ¨ç‰©ç±»å›ºé†‡æ¿€ç´ é€šå¸¸ç»“åˆ**èƒå†…å—ä½“**ï¼ˆæ ¸å—ä½“ï¼‰ï¼Œç›´æ¥ä½œä¸ºè½¬å½•å› å­è°ƒèŠ‚åŸºå› è¡¨è¾¾ï¼›è€Œæ¤ç‰©çš„BRsè¢«å®šä½åœ¨**ç»†èƒè†œè¡¨é¢çš„å—ä½“æ¿€é…¶ (BRI1)** æ„ŸçŸ¥ï¼Œé€šè¿‡èƒå†…ç£·é…¸åŒ–çº§è”ååº”å°†ä¿¡å·ä¼ é€’è‡³ç»†èƒæ ¸ã€‚

**Q2: Why are BR-deficient mutants dwarfed? (ä¸ºä»€ä¹ˆBRç¼ºé™·çªå˜ä½“æ˜¯çŸ®å°çš„ï¼Ÿ)**
**A:** BRs åœ¨æ¤ç‰©ä¸­ä¸»è¦è´Ÿè´£ä¿ƒè¿›**ç»†èƒä¼¸é•¿ (Cell elongation)** å’Œç»†èƒåˆ†è£‚ã€‚ç¼ºä¹BRï¼ˆåˆæˆçªå˜ä½“ï¼‰æˆ–æ— æ³•æ„ŸçŸ¥BRï¼ˆå—ä½“çªå˜ä½“ï¼‰ä¼šå¯¼è‡´ç»†èƒæ— æ³•æ­£å¸¸ä¼¸é•¿ï¼Œä»è€Œå¯¼è‡´æ¤æ ªæå…¶çŸ®å°ï¼ˆDwarfismï¼‰ã€‚

**Q3: How can manipulating BR pathways improve crop yield? (è°ƒæ§BRé€šè·¯å¦‚ä½•æé«˜ä½œç‰©äº§é‡ï¼Ÿ)**
**A:** é€‚åº¦é™ä½BRçš„åˆæˆï¼ˆå¦‚æ°´ç¨» *osdwarf4* çªå˜ä½“ï¼‰æˆ–å‡å¼±BRä¿¡å·ï¼Œå¯ä»¥ä½¿ä½œç‰©å¶ç‰‡å¤¹è§’å˜å°ï¼Œå‘ˆç°**ç›´ç«‹å¶ (Erect leaves)** å½¢æ€ã€‚è¿™ç§æ ªå‹æœ‰åˆ©äºå¯†æ¤ï¼Œå‡å°‘å¶ç‰‡é—´çš„é®é˜´ï¼Œæé«˜ç¾¤ä½“çš„å…‰åˆä½œç”¨æ•ˆç‡å’Œç”Ÿç‰©é‡ï¼Œä»è€Œå¢åŠ äº§é‡ã€‚

**Q4: What is the "Sequential Activation Model" of BR signaling? (BRä¿¡å·è½¬å¯¼çš„â€œé¡ºåºæ¿€æ´»æ¨¡å‹â€æ˜¯ä»€ä¹ˆï¼Ÿ)**
**A:** è¿™æ˜¯ä¸€ä¸ªç£·é…¸åŒ–çº§è”ååº”æ¨¡å‹ï¼šBRç»“åˆBRI1 $\rightarrow$ BRI1ä¸BAK1äº’ä½œå¹¶æ¿€æ´» $\rightarrow$ ç£·é…¸åŒ–å¹¶æ¿€æ´»BSK/CDG1 $\rightarrow$ æ¿€æ´»BSU1 (ç£·é…¸é…¶) $\rightarrow$ BSU1ä½¿BIN2 (æŠ‘åˆ¶å› å­) å»ç£·é…¸åŒ–è€Œå¤±æ´» $\rightarrow$ è§£é™¤BIN2å¯¹è½¬å½•å› å­BZR1/BES1çš„æŠ‘åˆ¶ $\rightarrow$ åŸºå› è¡¨è¾¾å¯åŠ¨ã€‚

        </script>

        <footer class="article-footer">
            <p>&copy; 2025 Yukari502. All rights reserved.</p>
            <p class="disclaimer">Disclaimer: Portions of this content may be generated by AI. Please exercise
                discretion and verify information independently.</p>
        </footer>
    </div>

    <script src="../../script.js"></script>
</body>

</html>